Lifeward Ltd. Appoints New Director, Reports Officer Compensation
Ticker: LFWD · Form: 8-K · Filed: May 19, 2025 · CIK: 1607962
Sentiment: neutral
Topics: director-change, officer-compensation
Related Tickers: RWLK
TL;DR
Lifeward Ltd. swapped a director and is talking officer pay.
AI Summary
Lifeward Ltd. announced on May 14, 2025, the departure of Director Dr. Alon Grode and the appointment of Dr. Yaron Bar-Tal as a new director. The company also reported on compensatory arrangements for certain officers, though specific details and dollar amounts were not provided in this excerpt.
Why It Matters
Changes in board composition and updates on executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns director changes and officer compensation, which are routine corporate events with typically low immediate risk.
Key Players & Entities
- Lifeward Ltd. (company) — Registrant
- Dr. Alon Grode (person) — Departing Director
- Dr. Yaron Bar-Tal (person) — Appointed Director
- May 14, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as a new director to Lifeward Ltd.'s board?
Dr. Yaron Bar-Tal has been appointed as a new director.
Who has departed from Lifeward Ltd.'s board of directors?
Dr. Alon Grode has departed from the board of directors.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 14, 2025.
What is the company's former name?
The company's former name was ReWalk Robotics Ltd. (changed on 20140620) and prior to that, Argo Medical Technologies Ltd. (changed on 20140513).
What is Lifeward Ltd.'s stock exchange listing?
Lifeward Ltd. is listed on NASDAQ.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 by Dr. Alon Grode regarding Lifeward Ltd. (LFWD).